Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
France
/
Materials
/
Arkema
AKE
Arkema
Asian Overcapacity And Regulatory Hurdles Will Erode Profitability
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
26 Jun 25
Updated
09 Aug 25
1
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€56.00
8.6% overvalued
intrinsic discount
09 Aug
€60.80
Loading
1Y
-22.0%
7D
5.8%
Author's Valuation
€56.0
8.6% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€56.0
8.6% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
11b
2014
2017
2020
2023
2025
2026
2028
Revenue €9.7b
Earnings €378.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.62%
Chemicals revenue growth rate
0.34%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.24%
Calculation
€378.81m
Earnings '28
x
14.41x
PE Ratio '28
=
€5.46b
Market Cap '28
€5.46b
Market Cap '28
/
77.72m
No. shares '28
=
€70.25
Share Price '28
€70.25
Share Price '28
Discounted to 2025 @ 8.18% p.a.
=
€55.48
Fair Value '25